open access

Vol 69, No 1 (2018)
Original papers
Published online: 2017-12-21
Submitted: 2017-09-02
Accepted: 2017-10-05
Get Citation

Sexual function and depressive symptoms in young men with hypothyroidism receiving levothyroxine/liothyronine combination therapy

Robert Krysiak, Bogdan Marek, Bogusław Okopień
DOI: 10.5603/EP.a2018.0005
·
Pubmed: 29319127
·
Endokrynologia Polska 2018;69(1):16-22.

open access

Vol 69, No 1 (2018)
Original papers
Published online: 2017-12-21
Submitted: 2017-09-02
Accepted: 2017-10-05

Abstract

Introduction: Both overt and subclinical hypothyroidism are often accompanied by sexual dysfunction. Despite improving male sexual functioning, levothyroxine treatment does not always restore all its aspects. The aim of this study was to compare male sexual function­ing and depressive symptoms between men with hypothyroidism receiving levothyroxine/liothyronine combination therapy and men receiving levothyroxine alone.

Material and methods: The study population consisted of 21 young levothyroxine-treated men with clinical symptoms of hypothyroid­ism, in whom serum thyrotropin and thyroid hormone levels were within the normal limits. In 11 of these patients, levothyroxine was replaced with levothyroxine/liothyronine combination therapy, while the remaining ones (n = 10) continued levothyroxine treatment. Beyond measuring serum levels of thyrotropin, free thyroxine, free triiodothyronine, and prolactin, before the beginning of the study and six months later, all enrolled patients completed questionnaires evaluating male sexual function (International Index of Erectile Func­tion-15: IIEF-15) and assessing the presence and severity of depressive symptoms (Beck Depression Inventory-Second Edition — BDI-II).

Results: The study included 10 patients from each group. At baseline, erectile function, intercourse satisfaction, orgasmic function, sexual desire and overall satisfaction, as well as the total BDI-II score did not differ between both groups. With the exception of an improvement in sexual desire, replacing levothyroxine with levothyroxine/liothyronine combination therapy did not affect sexual functioning and depressive symptoms.

Conclusions: The obtained results suggest that levothyroxine/liothyronine combination therapy has a relatively mild effect on sexual functioning in levothyroxine-treated men with normal thyrotropin and thyroid hormone levels experiencing clinical symptoms of hypo­thyroidism.

Abstract

Introduction: Both overt and subclinical hypothyroidism are often accompanied by sexual dysfunction. Despite improving male sexual functioning, levothyroxine treatment does not always restore all its aspects. The aim of this study was to compare male sexual function­ing and depressive symptoms between men with hypothyroidism receiving levothyroxine/liothyronine combination therapy and men receiving levothyroxine alone.

Material and methods: The study population consisted of 21 young levothyroxine-treated men with clinical symptoms of hypothyroid­ism, in whom serum thyrotropin and thyroid hormone levels were within the normal limits. In 11 of these patients, levothyroxine was replaced with levothyroxine/liothyronine combination therapy, while the remaining ones (n = 10) continued levothyroxine treatment. Beyond measuring serum levels of thyrotropin, free thyroxine, free triiodothyronine, and prolactin, before the beginning of the study and six months later, all enrolled patients completed questionnaires evaluating male sexual function (International Index of Erectile Func­tion-15: IIEF-15) and assessing the presence and severity of depressive symptoms (Beck Depression Inventory-Second Edition — BDI-II).

Results: The study included 10 patients from each group. At baseline, erectile function, intercourse satisfaction, orgasmic function, sexual desire and overall satisfaction, as well as the total BDI-II score did not differ between both groups. With the exception of an improvement in sexual desire, replacing levothyroxine with levothyroxine/liothyronine combination therapy did not affect sexual functioning and depressive symptoms.

Conclusions: The obtained results suggest that levothyroxine/liothyronine combination therapy has a relatively mild effect on sexual functioning in levothyroxine-treated men with normal thyrotropin and thyroid hormone levels experiencing clinical symptoms of hypo­thyroidism.

Get Citation

Keywords

depressive symptoms, hypothyroidism, levothyroxine, liothyronine, sexual functioning

About this article
Title

Sexual function and depressive symptoms in young men with hypothyroidism receiving levothyroxine/liothyronine combination therapy

Journal

Endokrynologia Polska

Issue

Vol 69, No 1 (2018)

Pages

16-22

Published online

2017-12-21

DOI

10.5603/EP.a2018.0005

Pubmed

29319127

Bibliographic record

Endokrynologia Polska 2018;69(1):16-22.

Keywords

depressive symptoms
hypothyroidism
levothyroxine
liothyronine
sexual functioning

Authors

Robert Krysiak
Bogdan Marek
Bogusław Okopień

References (31)
  1. Carani C, Isidori AM, Granata A, et al. Multicenter study on the prevalence of sexual symptoms in male hypo- and hyperthyroid patients. J Clin Endocrinol Metab. 2005; 90(12): 6472–6479.
  2. Krassas GE, Tziomalos K, Papadopoulou F, et al. Erectile dysfunction in patients with hyper- and hypothyroidism: how common and should we treat? J Clin Endocrinol Metab. 2008; 93(5): 1815–1819.
  3. Corona G, Wu FCW, Forti G, et al. EMAS Study Group. Thyroid hormones and male sexual function. Int J Androl. 2012; 35(5): 668–679.
  4. Maggi M, Buvat J, Corona G, et al. Hormonal causes of male sexual dysfunctions and their management (hyperprolactinemia, thyroid disorders, GH disorders, and DHEA). J Sex Med. 2013; 10(3): 661–677.
  5. Corona G, Petrone L, Mannucci E, et al. Psycho-biological correlates of rapid ejaculation in patients attending an andrologic unit for sexual dysfunctions. Eur Urol. 2004; 46(5): 615–622.
  6. Cihan A, Demir O, Demir T, et al. The relationship between premature ejaculation and hyperthyroidism. J Urol. 2009; 181(3): 1273–1280.
  7. Nikoobakht MR, Aloosh M, Nikoobakht N, et al. The role of hypothyroidism in male infertility and erectile dysfunction. Urol J. 2012; 9(1): 405–409.
  8. Abalovich M, Levalle O, Hermes R, et al. Hypothalamic-pituitary-testicular axis and seminal parameters in hyperthyroid males. Thyroid. 1999; 9(9): 857–863.
  9. Krysiak R, Szkróbka W, Okopień B. The effect of l-thyroxine treatment on sexual function and depressive symptoms in men with autoimmune hypothyroidism. Pharmacol Rep. 2017; 69(3): 432–437.
  10. Escobar-Morreale HF, Botella-Carretero JI, Escobar del Rey F, et al. REVIEW: Treatment of hypothyroidism with combinations of levothyroxine plus liothyronine. J Clin Endocrinol Metab. 2005; 90(8): 4946–4954.
  11. Escobar-Morreale HF, Botella-Carretero JI, Morreale de Escobar G. Treatment of hypothyroidism with levothyroxine or a combination of levothyroxine plus L-triiodothyronine. Best Pract Res Clin Endocrinol Metab. 2015; 29(1): 57–75.
  12. Bunevicius R, Kazanavicius G, Zalinkevicius R, et al. Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. N Engl J Med. 1999; 340(6): 424–429.
  13. Fadeyev VV, Morgunova TB, Melnichenko GA, et al. Combined therapy with L-thyroxine and L-triiodothyronine compared to L-thyroxine alone in the treatment of primary hypothyroidism. Hormones (Athens). 2010; 9(3): 245–252.
  14. Rosen RC, Cappelleri JC, Gendrano N. The International Index of Erectile Function (IIEF): a state-of-the-science review. Int J Impot Res. 2002; 14(4): 226–244.
  15. Cappelleri JC, Rosen RC, Smith MD, et al. Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. Urology. 1999; 54(2): 346–351.
  16. Beck AT, Steer RA, Brown GK. BDI-II: Beck Depression Inventory Manual. Edn 2. Psychological Corporation, San Antonio 1996.
  17. American Psychiatric Association. Diagnostic and statistical manual of mental disorders - DSM-IV-TR. Edn 4. American Psychiatric Publishing, Washington 1994.
  18. Escobar-Morreale HF, Obregón MJ, Escobar del Rey F, et al. Replacement therapy for hypothyroidism with thyroxine alone does not ensure euthyroidism in all tissues, as studied in thyroidectomized rats. J Clin Invest. 1995; 96(6): 2828–2838.
  19. Escobar-Morreale HF, del Rey FE, Obregón MJ, et al. Only the combined treatment with thyroxine and triiodothyronine ensures euthyroidism in all tissues of the thyroidectomized rat. Endocrinology. 1996; 137(6): 2490–2502.
  20. Krysiak R, Drosdzol-Cop A, Skrzypulec-Plinta V, et al. Sexual function and depressive symptoms in young women with elevated macroprolactin content: a pilot study. Endocrine. 2016; 53(1): 291–298.
  21. Krysiak R, Gilowska M, Okopień B. Sexual function and depressive symptoms in young women with low vitamin D status: a pilot study. Eur J Obstet Gynecol Reprod Biol. 2016; 204: 108–112.
  22. Davis SR, Worsley R, Miller KK, et al. Androgens and Female Sexual Function and Dysfunction--Findings From the Fourth International Consultation of Sexual Medicine. J Sex Med. 2016; 13(2): 168–178.
  23. Holloway V, Wylie K. Sex drive and sexual desire. Curr Opin Psychiatry. 2015; 28(6): 424–429.
  24. Wylie K, Rees M, Hackett G, et al. Androgens, health and sexuality in women and men. Hum Fertil (Camb). 2010; 13(4): 277–297.
  25. Tahmaz L, Gökalp A, Kibar Y, et al. Effect of hypothyroidism on the testes in mature rats and treatment with levothyroxine and zinc. Andrologia. 2000; 32(2): 85–89.
  26. Jabbar A, Pingitore A, Pearce SHS, et al. Thyroid hormones and cardiovascular disease. Nat Rev Cardiol. 2017; 14(1): 39–55.
  27. König S, Moura Neto V. Thyroid hormone actions on neural cells. Cell Mol Neurobiol. 2002; 22(5-6): 517–544.
  28. Maran RR, Arunakaran J, Aruldhas MM. T3 directly stimulates basal and modulates LH induced testosterone and oestradiol production by rat Leydig cells in vitro. Endocr J. 2000; 47(4): 417–428.
  29. Pilo A, Iervasi G, Vitek F, et al. Thyroidal and peripheral production of 3,5,3'-triiodothyronine in humans by multicompartmental analysis. Am J Physiol. 1990; 258(4 Pt 1): E715–E726.
  30. Wiersinga WM. Thyroid hormone replacement therapy. Horm Res. 2001; 56 Suppl 1: 74–81.
  31. Szybiński Z. Polish Council for Control of Iodine Deficiency Disorders. Work of the Polish Council for Control of Iodine Deficiency Disorders, and the model of iodine prophylaxis in Poland. Endokrynol Pol. 2012; 63(2): 156–160.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl